Finance

Beta
Lists
AARD:NASDAQ
Aardvark Therapeutics Inc
$3.59
+0.28%
(+0.0100) 1D
Jun 10, 2:18:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AARD...
Open
$3.56
High
$3.69
Low
$3.52
Mkt. cap
78.65M
Avg. vol.
164.07K
Volume
50.98K
52-wk high
$17.94
52-wk low
$3.35
EPS
-$3.21
Shares outstanding
21.82M
No. of employees
40
Open
$3.56
High
$3.69
Low
$3.52
Mkt. cap
78.65M
Avg. vol.
164.07K
Volume
50.98K
52-wk high
$17.94
52-wk low
$3.35
EPS
-$3.21
Shares outstanding
21.82M
No. of employees
40
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to AARD in the past 3 months
Hold
Buy
2
Hold
2
Sell
2
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AARD in the last 3 months.
Highest
Current $3.59
$7.00 (+94.99%)
Average
$5.00 (+39.28%)
Lowest
$3.00 (-16.43%)
News stories
From sources across the web
About Aardvark Therapeutics Inc
CEO-
Employees40
Founded2017
Headquarters-
SectorPharmaceutical industry
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.99 / -$0.92
-8.11%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13.14M
13.74M
14.30M
16.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.70M
3.97M
4.40M
5.90M
Operating expense
15.85M
17.70M
18.70M
22.46M
Total operating expenses
15.85M
17.70M
18.70M
22.46M
Operating income
-15.85M
-17.70M
-18.70M
-22.46M
Other non operating income
-
-
-
-
EBT including unusual items
-14.37M
-16.32M
-17.60M
-21.59M
EBT excluding unusual items
-14.36M
-16.35M
-17.58M
-21.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.37M
-16.32M
-17.60M
-21.59M
Net profit margin
-
-
-
-
Earnings per share
-0.66
-0.75
-0.81
-0.99
Interest and investment income
1.49M
1.35M
1.12M
889.00K
Interest expense
-
-
-
-
Net interest expenses
1.49M
1.35M
1.12M
889.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.84M
-17.69M
-18.69M
-22.45M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more